NOVARTIS PHARMACEUTICALS CORPORATION – Trademark Portfolio

Entity Type: 03

NOVARTIS PHARMACEUTICALS CORPORATION holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. Currently, 8 trademarks are registered. Notable registered marks include GENTEAL, CAFERGOT, EYESCRUB, LOTENSIN, and LOPRESSOR. The owner is based in EAST HANOVER, NJ.

ONE HEALTH PLAZA

EAST HANOVER, NJ 079361080

16 Total Trademarks

Add to watchlist:

No watchlists yet

+ Create New Watchlist

All (16) Registered (8) Cancelled (8)

Sort by:

By Date

By Name

Filter by Class:

GENTEAL

Registered 1996

Cancelled 1991

Registered 1991

Registered 1990

Registered 1989

HYPOTEARS

Cancelled 1986

Registered 1979

Cancelled 1977

Cancelled 1977

Registered 1976

Cancelled 1970

Cancelled 1965

TORECAN

Cancelled 1960

FIORINAL

Cancelled 1951

CAFERGOT

Registered 1950

METHERGINE

Registered 1942

Trademark Classifications

NOVARTIS PHARMACEUTICALS CORPORATION's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does NOVARTIS PHARMACEUTICALS CORPORATION have?

NOVARTIS PHARMACEUTICALS CORPORATION has 16 U.S. trademarks filed with the USPTO. Of these, 8 registered, 8 cancelled.

What trademark classes does NOVARTIS PHARMACEUTICALS CORPORATION file in?

NOVARTIS PHARMACEUTICALS CORPORATION files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NOVARTIS PHARMACEUTICALS CORPORATION's most well-known trademarks?

NOVARTIS PHARMACEUTICALS CORPORATION's registered trademark portfolio includes well-known marks such as GENTEAL, CAFERGOT, EYESCRUB, LOTENSIN, and LOPRESSOR. These are among 8 currently registered trademarks in the portfolio.

What is NOVARTIS PHARMACEUTICALS CORPORATION's trademark registration success rate?

NOVARTIS PHARMACEUTICALS CORPORATION has a 50% trademark registration rate, with 8 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.